CGAS and metabolic dysfunction-associated steatotic liver disease: Moreover, although cGAS-STING signalling affects liver injury, hepatocellular carcinoma (HCC), non-alcoholic fatty liver disease (NAFLD) and viral hepatitis [8], the detailed mechanism of cGAS-STING signalling in liver inflammation remains unexplored.